ATE267832T1 - Substanz gm-95, verfahren zu ihrer herstellung und ihre verwendung - Google Patents
Substanz gm-95, verfahren zu ihrer herstellung und ihre verwendungInfo
- Publication number
- ATE267832T1 ATE267832T1 AT99949337T AT99949337T ATE267832T1 AT E267832 T1 ATE267832 T1 AT E267832T1 AT 99949337 T AT99949337 T AT 99949337T AT 99949337 T AT99949337 T AT 99949337T AT E267832 T1 ATE267832 T1 AT E267832T1
- Authority
- AT
- Austria
- Prior art keywords
- compound
- production
- medicine
- substance
- chem
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 239000000126 substance Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 7
- 239000003814 drug Substances 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 230000000259 anti-tumor effect Effects 0.000 abstract 1
- 244000005700 microbiome Species 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
- C12P17/185—Heterocyclic compounds containing sulfur atoms as ring hetero atoms in the condensed system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains four or more hetero rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Compounds Of Unknown Constitution (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP30263498 | 1998-10-23 | ||
| PCT/JP1999/005806 WO2000024747A1 (en) | 1998-10-23 | 1999-10-20 | Substance gm-95, process for producing the same and utilization thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE267832T1 true ATE267832T1 (de) | 2004-06-15 |
Family
ID=17911355
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99949337T ATE267832T1 (de) | 1998-10-23 | 1999-10-20 | Substanz gm-95, verfahren zu ihrer herstellung und ihre verwendung |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US6613759B1 (de) |
| EP (1) | EP1123937B1 (de) |
| KR (1) | KR100446323B1 (de) |
| AT (1) | ATE267832T1 (de) |
| AU (1) | AU770166B2 (de) |
| CA (1) | CA2346201C (de) |
| DE (1) | DE69917668T2 (de) |
| DK (1) | DK1123937T3 (de) |
| ES (1) | ES2217815T3 (de) |
| PT (1) | PT1123937E (de) |
| WO (1) | WO2000024747A1 (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1350794B1 (de) * | 2000-12-12 | 2005-06-22 | Sosei Co., Ltd. | Verfahren zur herstellung von substanz gm-95 |
| US7045523B2 (en) | 2001-10-18 | 2006-05-16 | Novartis Ag | Combination comprising N-{5-[4-(4-methyl-piperazino-methyl)-benzoylamido]-2-methylphenyl}-4-(3-pyridyl)-2-pyrimidine-amine and telomerase inhibitor |
| WO2004074295A1 (ja) * | 2003-02-21 | 2004-09-02 | Keio University | チアゾール環状多量体、その製造方法、その合成中間体およびその利用 |
| EP1602659A1 (de) * | 2003-03-04 | 2005-12-07 | Sosei Co., Ltd. | Gm-95-haltiges, die antitumorwirkung verstärkendes mittel, kombinierte antitumorzubereitung und antitumormittel |
| JP2006160723A (ja) * | 2004-11-10 | 2006-06-22 | Marine Biotechnol Inst Co Ltd | 抗腫瘍活性を有する化合物及びその製造方法 |
| US7556949B2 (en) * | 2006-10-30 | 2009-07-07 | E.I. Du Pont De Nemours And Company | Δ17 desaturase and its use in making polyunsaturated fatty acids |
| DE102014205356A1 (de) * | 2014-03-21 | 2015-09-24 | Robert Bosch Gmbh | Elektrode für eine Lithium-Zelle |
| CN110283762B (zh) * | 2019-08-01 | 2020-09-22 | 哈尔滨天齐人类第二基因组技术开发应用科技有限责任公司 | 一株具有强力抗癌活性的链霉菌ccpm7649及其应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1061482B (de) * | 1958-04-29 | 1959-07-16 | R I T Rech Et Ind Therapeutiqu | Verfahren zur Reinigung des Antibiotikums 899 |
| EP0269322B1 (de) | 1986-11-21 | 1992-12-23 | Merck & Co. Inc. | Fermentationsanaloge von Virginiamycin-M1 |
| US5434260A (en) | 1992-10-13 | 1995-07-18 | American Home Products Corporation | Carbamates of rapamycin |
| EP0849267B1 (de) * | 1996-12-18 | 2001-09-26 | Kyowa Hakko Kogyo Co., Ltd. | Furoindolizine |
| JPH11180997A (ja) * | 1997-12-24 | 1999-07-06 | Yamanouchi Pharmaceut Co Ltd | 新規抗腫瘍化合物 |
-
1999
- 1999-10-20 KR KR10-2001-7004868A patent/KR100446323B1/ko not_active Expired - Fee Related
- 1999-10-20 DE DE69917668T patent/DE69917668T2/de not_active Expired - Fee Related
- 1999-10-20 EP EP99949337A patent/EP1123937B1/de not_active Expired - Lifetime
- 1999-10-20 PT PT99949337T patent/PT1123937E/pt unknown
- 1999-10-20 WO PCT/JP1999/005806 patent/WO2000024747A1/ja not_active Ceased
- 1999-10-20 ES ES99949337T patent/ES2217815T3/es not_active Expired - Lifetime
- 1999-10-20 CA CA002346201A patent/CA2346201C/en not_active Expired - Fee Related
- 1999-10-20 AU AU62277/99A patent/AU770166B2/en not_active Ceased
- 1999-10-20 DK DK99949337T patent/DK1123937T3/da active
- 1999-10-20 AT AT99949337T patent/ATE267832T1/de not_active IP Right Cessation
- 1999-10-20 US US09/806,475 patent/US6613759B1/en not_active Expired - Fee Related
-
2003
- 2003-03-31 US US10/401,589 patent/US7192763B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP1123937A1 (de) | 2001-08-16 |
| AU6227799A (en) | 2000-05-15 |
| DE69917668D1 (de) | 2004-07-01 |
| US20030191165A1 (en) | 2003-10-09 |
| EP1123937A9 (de) | 2001-11-14 |
| DK1123937T3 (da) | 2004-10-11 |
| PT1123937E (pt) | 2004-09-30 |
| DE69917668T2 (de) | 2005-05-19 |
| KR100446323B1 (ko) | 2004-08-30 |
| KR20010103610A (ko) | 2001-11-23 |
| EP1123937B1 (de) | 2004-05-26 |
| CA2346201A1 (en) | 2000-05-04 |
| CA2346201C (en) | 2007-06-05 |
| WO2000024747A1 (en) | 2000-05-04 |
| AU770166B2 (en) | 2004-02-12 |
| ES2217815T3 (es) | 2004-11-01 |
| US6613759B1 (en) | 2003-09-02 |
| US7192763B2 (en) | 2007-03-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ337861A (en) | N-heterocyclic derivatives for treating multiple sclerosis, HIV dementia, Parkinson's disease, meningitis, atherosclerosis, cancer, inflammatory skin diseases | |
| DE3775882D1 (de) | Substituierte 6-fluor-4-oxo-1,4-dihydrochinolin-3-carbonsaeuren ; deren derivate; diese verbindung enthaltende pharmazeutische zubereitungen und verfahren zur herstellung dieser verbindungen. | |
| HU9600834D0 (en) | Quinazoline derivatives | |
| PT1004578E (pt) | Derivados hidroxamida do acido 5-oxo-pirrolidino-2-carboxilico | |
| HUT58334A (en) | Process for producing diazines and pharmaceutical compositions containing them as active components | |
| ATE246180T1 (de) | Benzofuranon-derivate und verfahren zu ihrer herstellung | |
| ATE206926T1 (de) | Verwendung eines phosphorsäurediesters zur herstellung eines arzneimittels zur behandlung von akne | |
| DE3873578D1 (de) | Verwendung von tetrahydrobenz(c,d)indol-6-carboxamiden zur herstellung von arzneimitteln zur behandlung von angstzustaenden. | |
| ATE247645T1 (de) | Neue piperazinylalkylthiopyrimidine derivate, diese enthaltende pharmazeutische zusammenstellungen und verfahren zu deren herstellung | |
| NO173444C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive 4-(4'- fluorfenyl-)-tienopyridin-derivater | |
| ATE267832T1 (de) | Substanz gm-95, verfahren zu ihrer herstellung und ihre verwendung | |
| ATE115558T1 (de) | Harnstoffderivate, deren herstellung sowie diese enthaltende pharmazeutische zusammensetzungen. | |
| ATE165822T1 (de) | Chinolin-4-carbonylguanidin-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen | |
| DE60041137D1 (de) | Ceramid ähnliche verbindungen, verfahren zu deren herstellung und deren verwendung als antitumormittel | |
| BR9610175A (pt) | Composto processo de preparação do composto composição farmacêutica e utilização do composto | |
| ATE214375T1 (de) | Piperazinylalkylthiopyrimidin derivate, diese enthaltende pharmazeutische zusammensetzungen und verfahren zu deren herstellung | |
| ATE421961T1 (de) | Piperidinderivate, verfahren zu deren herstellung und pharmazeutische zusammensetzung zur behandlung von alzheimer-krankheit, die diese derivate enthält | |
| AU695190B2 (en) | Substance FA-70D, process for producing the same, and uses thereof | |
| NO20031137D0 (no) | Fremgangsmåte for fremstilling av kirale forbindelser | |
| DE69511449D1 (de) | Octahydro-2-Naphthalincarbonsäure-Derivate, ihre Herstellung und Verwendung | |
| HUT57746A (en) | Process for producing new 1,3-oxazines and pharmaceutical compositions comprising same | |
| EP0721985A4 (de) | Die substanz it-62-b und sie enthaltende medizinische zubereitungen | |
| DE69902537D1 (de) | Eine verbindung, wf002, ein verfahren zu ihrer herstellung und ihre verwendung | |
| MXPA04004537A (es) | Derivados de gabusectina, metodo para produccion de los mismos y uso de los mismos. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1123937 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |